Earnings Labs

Flotek Industries, Inc. (FTK)

Q3 2018 Earnings Call· Wed, Nov 7, 2018

$16.84

-1.98%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

-25.10%

1 Week

-32.10%

1 Month

-48.97%

vs S&P

-42.96%

Transcript

Operator

Operator

Good morning, and welcome to the Flotek Industries Inc., Third Quarter 2018 Earnings Conference Call. All participants will be in a listen-only mode. And there will be an opportunity for you to ask questions at the end of the Company’s prepared remarks. And operator will provide instructions on how to ask questions at that time. [Operator Instructions] This conference is being recorded. At this time, I would like to turn the conference over to Matt Marietta, Flotek's Executive Vice President of Finance and Corporate Development. Mr. Marietta, you may begin.

Matthew Marietta

Analyst

Thank you, and good morning on behalf of the Flotek team. Joining me this morning are John Chisholm, Flotek's Chairman, President and Chief Executive Office; Rich Walton, our Chief Accounting Officer; and Josh Snively, Executive Vice President and Head of Operations as well as other members of our leadership team. Our earnings press release was distributed yesterday afternoon in conjunction with the third quarter earnings supplement presentation, both of which are available on our website. In addition, today's call is being webcast, and a replay will be available on our website. Before we begin our formal remarks, I would like to remind participants that during this call, some of the comments made may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and other applicable statutes reflecting Flotek's views, comments or expectations about future events and their potential impact on performance. Words such as expects, anticipates, plans, believes, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not an exclusive means of identifying such forward-looking statements. These matters involve risks and uncertainties that could cause our actual results to differ from such forward-looking statements. Risks are discussed in our SEC filings, including our Form 10-K. Also please refer to our reconciliations provided in our earnings press release as management may discuss non-GAAP metrics on this call. With that, I'll turn the call over to John Chisholm.

John Chisholm

Analyst

Thanks Matt. And thanks for hanging in there and being under the weather. And thank you all for joining today's call. I'd like to thank all of the Flotek employees for their hard work and our stakeholders for their support. The structure of today's call will be a little bit different from previous quarters. We posted a supplemental slide deck to our website, which will serve as a useful visual guide to some of the key items discussed today. Additionally, in the interest of being direct, concise and transparent to our shareholders, and to leave more time for Q&A, I'll take you through key highlights for the quarter; let Matt come back, provide a brief financial update, and then return with my thoughts on today's industry context, how Flotek is providing value to the market, and conclude with outlook and guidance. We will then open the line for questions for which Josh Snively and Matt and our leadership group will be available to elaborate. In the context of recent reports on the industry activity levels in the third quarter and into the fourth quarter, I'm proud of what we have accomplished in the progress made today. Flotek’s third quarter consolidated revenues increased 20% sequentially due to increased demand for Complex nano-Fluid known as CnF, driven by unconventional activity in the Middle East by NOCs. Adjusted EBITDA of $2 million represents a 51% incremental margin from last quarter and a $6 million sequential improvement from the second quarter. These strong incrementals were made possible by increased CnF sales abroad, our continued expansion in the higher margin Flavor and Fragrance opportunities at Florida Chemical and our relentless focus on cost reduction. In fact, we removed an additional $3 million of annualized cash SG&A during the quarter and have now reduced cash SG&A…

Matthew Marietta

Analyst

Thank you, John. In an effort to streamline the earnings call, I believe the line item detail of our financial review to the earnings press release and our Form 10-Q, which has been filed with the Securities and Exchange Commission and does contain important disclosures. I will focus on steps we are taking to improve our cash flow efficiency as we manage our balance sheet. Our aggressive cost reduction programs continue across our organization and we have even started a program that directly incentivizes our employees to find areas of further savings. This initiative has been met with great enthusiasm across our Company. More details of our SG&A reduction progress have been shared on Slide 4 in a slide deck published to our website yesterday afternoon. We remain committed to lowering our SG&A as a percentage of revenue to a level that maximizes our free cash flow. We have made changes in our ECT logistic strategy and focused heavily on freight expenses, which were relative context if you were to assume a static product mix and shipments is designed to benefit our gross margins by approximately 5 percentage points on a run rate basis by year-end compared to the third quarter. Our balance sheet remains larger than we would like due to our inventory position of which is mostly citrus oils as a result of greater purchases from South America to start the year and underperformance of internal consumption we have faced within our Energy segment in the first half of 2018. We have limited committed purchases of inventory remaining for the year and we expect that consolidated inventory balances to decline by roughly $10 million into year-end. Additionally, our DSOs have extended due to a greater component of international sales in the third quarter, which customarily carry longer terms…

John Chisholm

Analyst

Thanks again, Matt. Over the past year, the new reality of some of the issues facing the energy industry is now more apparent than ever. While we have said this for some time, operators are seeing diminishing returns on increased profit loading, fluid loading and lateral length evidence as analysts and clients alike review production data from the last three years and operators are now defining an upper boundary for these mechanical factors in their completion designs. Further supporting this point, Raymond James and the economist recently issued independent reports indicating well productivity growth is slowing depicted in Slide 7 and 8 in our accompanying presentation. Thus, the drive for capital efficiency to get more barrels out for lower costs is becoming the most critical focus of operators today and an opportunity for Flotek to help our clients, deliver more value, greater returns through a prescriptive chemistry experience. We're doing this by partnering with operators to optimize their fluid designs and increase their capital efficiency as highlighted in Slide 9. In one specific case, as this highlighted in Slide 10, we partnered with a Mid-Con operator to design and tailor their fluid system for their reservoir. By switching to a more effective fluid system, we were able to reduce overall chemistry spend per well, optimize horsepower efficiency and reduce fluid reservoir in compatibility. In total, our clients $1.9 million per month, which translates to more than $20 million in cost benefit per year for their program, while producing better wells. I also want to point out our fluid system benefited our service company partner due to lower required operational horsepower needed to deliver profit and less overall wear and tear on their fluid ends. Another key challenge for our clients in the industry to achieving greater capital efficiency is infill…

Operator

Operator

[Operator Instructions] And we have a question from Georg Venturatos with Johnson Rice. Please go ahead.

Georg Venturatos

Analyst

Hey. Good morning, guys.

John Chisholm

Analyst

Good morning, Georg.

Georg Venturatos

Analyst

Well, John, appreciate all those details there. I think where I kind of wanted to start was Energy Chemistry and the thing that was the largest positive surprise here in the release other than quarterly results, so just your outlook, and it seems like your visibility into October and November, which kind of bucks the trend, which we've heard a lot across the service side. So I just wanted to get a sense of where you kind of see that that direct sale percentage of a ECT sales kind of an exit rate basis this year and just kind of how that's helping you see the market a little clearer, at least a couple months ahead of time albeit I know December is a big wildcard, but just wanted to hear you talk a little bit more about that and how that's kind of coming together?

John Chisholm

Analyst

Sure. Well, we have felt this for some time, Georg that is more of these clients move directly to engaging us. We do have better visibility. November is the best visibility we've had of any month. And more of this business is, we wouldn't say is contracted, but it is more scheduled is we're following more and more frac fleets, so it's not as spot as it was when we started this whole PCM initiative a year ago. So it's becoming more regular, more predictable and a greater interaction directly with the operator. And as I mentioned in our commentary, that is growing undeniably. Josh, you may want to chime in anything. But again, the visibility is at the highest we've seen it.

Joshua Snively

Analyst

Yes, thanks John, and good morning, Georg. The direct operator model takes a little more coordination and getting our chemistries on site, so that gives us a tighter connection with our clients, allows us to do our supply chain better and does give us better visibility into our field utilizations. So the model is helping us as we've evolved over the last 10 months and getting better at this visibility and working with our clients on what their frac schedules are and what products are we’ll need on site. That in turn takes our efficiencies up greatly, not only from field crew utilization, but also our logistics activities as well.

John Chisholm

Analyst

Georg, maybe to be a little bit more direct for you and for the folks listening in domestically, right around two-thirds of our revenue is directly through the PCM model, which is directly to the EMP operator. Does that help?

Georg Venturatos

Analyst

Got it. That's good. Thanks John. And then just given what you're seeing over the last or at least October, November and you talked a little bit about, you talked to about it from a customer perspective and revenue per customer, but just from a base in perspective, particularly given the pressure we're anticipating in Q4 relative to Permian takeaway, just anything that jumps out from a base in a perspective that is out of the ordinary?

John Chisholm

Analyst

Sure. I'm not sure we describe it as out of the ordinary, but it was a pleasant surprise. The Anadarko area has doubled in our revenue base since the start of the year. And that's undoubtedly help counterbalance some of the issues in the Permian, although the Permian, like everybody else, we're still overweighed that's our number one area. And I would again refer you and our listeners to Slide 5. One thing that's happening is the average revenue per client is up. In a period where people are still obviously focusing on a lot of costs, but I think we've tried to really translate cost into benefit and also the number of major domestic clients is defined by us is up 16% in the quarter over the second quarter. So it's a broadening of the base and that client base is getting more and more comfortable of the expenditure on chemistry. The one case study I mentioned in the prepared remarks though, keep in mind, part of that success was we actually provided less dollar chemistry to create the capital efficiency and that led to and has led to an ongoing relationship. So it's not so much selling more dollars initially. It's to prescribing the right chemistry to be able to have the reservoir create the best opportunity for capital efficiency.

Georg Venturatos

Analyst

Got it. Internationally, you guys mentioned the decline sequentially, but it sounds like that is at least the Middle East as a whole is continuing to be a growing market for you guys and on a baseline perspective – the NOC contract that impacted 3Q, would you anticipate that baseline revenue out of the region is sequentially higher in Q4?

John Chisholm

Analyst

Yes, we do. I think a lot of the people on the call listening in have an appreciation of this have not the international activity typically takes longer to sell and the business model is not near as uniform as it is that everybody's accustomed to here in the United States. Just to give you one example, for heaven sakes, it's very difficult to get two or three stages off per day when you're dealing with 120 degrees temperature is just very hard. So it's a mistake to apply domestic performance into some of these international areas. That's what's relates to the choppiness. But to get back to your central question, again in the Middle East, the market is expanding both geographically inside the Middle East overall and from a client perspective as well.

Georg Venturatos

Analyst

Okay. And then maybe John or Matt. I wanted to just touch on the balance sheet side and you guys mentioned, after the working cap requirements this quarter, expect that had positive benefit in Q4, but just maybe you can elaborate a little bit more on the working, the parts of that. Just I know you mentioned international receivables that were going to be helpful. But just elaborate on that and then also any targets for kind of availability as we work through 2019 on the revolver side?

John Chisholm

Analyst

Yes, Georg, I'll take the first question there. We were able to provide that from number on inventory and the prepared remarks. As we look at accounts receivable and try to do some math on those accounts or that account, we do anticipate that we could release as much as $10 million out of accounts receivable based on a revenue expectation. But of course, if our revenue expectation approved to be conservative, we'll happily fund more accounts receivable growth in the fourth quarter, but based on what we've put out there as our initial expectations that that would be the math. So we do anticipate working capital to be a significant source of funds, but further to that – further reductions in SG&A are on going to help improve the performance of the business. 2019, is a bit difficult to comment on today. We haven't seen a lot of capital budget announcements from our client base. So it's a little bit challenging, but we are focused on monetizing the inventory position on the balance sheet and are doing things today commercially to push that inventory through our P&L. So we're obviously aware of where we're at in working capital, but we do have a plan in place and we are executing on the plan to relieve some of that working capital before the end of the year.

Georg Venturatos

Analyst

Got it. Appreciate the answer guys. End of Q&A

Operator

Operator

[Operator Instructions]

John Chisholm

Analyst

Thank you, operator for conducting the call. Thanks for all of our folks that listen in. We hope the slides were helpful. It's a new approach. I imagine we're going to continue that as we move forward and as we mentioned, we'll look forward to be giving you progress as we move through the rest of the year heading into 2019. And again, we certainly appreciate everyone's support. Thank you very much.

Operator

Operator

Ladies and gentlemen, that does conclude the call for today. We thank you for your participation and ask that you please disconnect your line.